Arta Monir Monjazeb

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma
    Robert J Canter
    Department of Surgery, Division of Surgical Oncology, University of California Davis Medical Center, 4501 X Street, Sacramento, CA 95817, USA
    BMC Cancer 14:756. 2014
  2. ncbi request reprint A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme
    Arta M Monjazeb
    Department of Radiation Oncology, UC Davis School of Medicine, Sacramento, CA 95817, USA
    Int J Radiat Oncol Biol Phys 82:743-8. 2012
  3. ncbi request reprint The impact of multimodality therapy of distal esophageal and gastroesophageal junction adenocarcinomas on treatment-related toxicity and complications
    Arta Monir Monjazeb
    Department of Radiation Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA 95816, USA
    Semin Radiat Oncol 23:60-73. 2013

Collaborators

  • Thomas L Ellis
  • Michael D Chan
  • Robert J Canter
  • Rachel C Smith
  • Steven K Grossenbacher
  • Joe Tellez
  • Stephanie Mac
  • Thomas J Sayers
  • Dariusz Borys
  • Chin Shang Li
  • Mingyi Chen
  • Erik Ames
  • William J Murphy

Detail Information

Publications3

  1. ncbi request reprint Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma
    Robert J Canter
    Department of Surgery, Division of Surgical Oncology, University of California Davis Medical Center, 4501 X Street, Sacramento, CA 95817, USA
    BMC Cancer 14:756. 2014
    ..We hypothesized that TKIs would have differential effects on CSC populations depending on their mechanism of action (anti-proliferative vs. anti-angiogenic)...
  2. ncbi request reprint A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme
    Arta M Monjazeb
    Department of Radiation Oncology, UC Davis School of Medicine, Sacramento, CA 95817, USA
    Int J Radiat Oncol Biol Phys 82:743-8. 2012
    ..To describe the results of a Phase I dose escalation trial for newly diagnosed glioblastoma multiforme (GBM) using a hypofractionated concurrent intensity-modulated radiotherapy (IMRT) boost...
  3. ncbi request reprint The impact of multimodality therapy of distal esophageal and gastroesophageal junction adenocarcinomas on treatment-related toxicity and complications
    Arta Monir Monjazeb
    Department of Radiation Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA 95816, USA
    Semin Radiat Oncol 23:60-73. 2013
    ..Late toxicities are less well defined, but commonly include esophageal, pulmonary, and cardiac toxicities...